//
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial
Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials
How Low to Go With Glucose, Cholesterol, and Blood Pressure in Primary Prevention of CVD
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk
Routinely reported ejection fraction and mortality in clinical practice: where does the nadir of risk lie?
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes Research
Defining Staged Procedures for Percutaneous Coronary Intervention Trials A Guidance Document
Screening for Atrial Fibrillation With ECG: USPSTF Recommendation